4basebio logo

4basebio

Next generation gene therapy

102 employees · est. 1997 · Cambridge, United Kingdom

VS
Gennao Bio logo

Gennao Bio

A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics

5 employees · est. 2020 · Hopewell, United States

4basebio is the older company (1997 vs 2020); 4basebio is the larger of the two.

Side-by-Side Comparison

4basebio Gennao Bio
Founded
1997 older 2020
Headquarters
Cambridge, United Kingdom Hopewell, United States
Employees
102 larger 5
Industry
Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Grant Series A
Total Funding
$299.20K Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Gene Therapy, Synthetic DNA, MRNA Technology, Non-viral Vectors, Nucleic Acid Delivery Systems, Genome Editing, Vaccines, Therapeutics, Nanoparticle Technology, DNA Manufacturing, Life Science Technology Genetic Medicines, Nucleic Acid Therapeutics, Targeted Therapeutics, GMAB Platform Technology, Cell-Penetrating Antibody, Non-Viral Delivery System, Oncology Therapeutics, Rare Monogenic Diseases, Skeletal Muscle Diseases, MRNA Delivery, SiRNA Delivery, Gene Editing, Antisense Oligonucleotides, Therapeutic Payload Delivery
Website
4basebio.com gennao.com
4basebio logo

About 4basebio

4basebio is a United Kingdom-based biotechnology startup focusing on next-generation gene therapy and vaccine development. With a founding year of 1997, the company has been pioneering the advancement of cell and gene therapies through its innovative technologies. Their synthetic DNA and mRNA soluti...

Gennao Bio logo

About Gennao Bio

Gennao Bio is a pioneering force in the realm of genetic medicine, established in 2020. With its focus on developing first-in-class nucleic acid therapeutics, the company sets itself apart through its unique Gene Monoclonal Antibody (GMAB) platform technology. This innovative platform employs a nove...

We will tell you when either one moves

BounceWatch watches 4basebio and Gennao Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at 4basebio and Gennao Bio — by email.

Frequently Asked Questions

4basebio — Next generation gene therapy. Gennao Bio — A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
4basebio has raised $299.20K while Gennao Bio has raised undisclosed funding.
4basebio and Gennao Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare 4basebio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at 4basebio on 12 Sep 2024, and Gennao Bio on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy